Objectives-To evaluate an increase in plasma concentration of thiobarbituric acid reactive substances as a non-invasive biochemical test of reperfusion after thrombolysis and to investigate the relation between the inflammatory response after acute myocardial infarction and the production of the substances. Methods-Venous samples were taken from 19 patients receiving thrombolysis for acute myocardial infarction before the start of therapy and every hour afterwards up to 5 hours and then at 24 and 48 hours and the concentration of thiobarbituric acid reactive substances measured. These substances are markers of lipid peroxidation induced by free oxygen radicals. Early reperfusion was judged by regression of ST elevation and late coronary artery patency from the results of coronary angiography 24-72 hours after thrombolysis. Results-The concentration of thiobarbituric acid reactive substances increased in only 6 out of 14 patients with signs of early reperfusion. In patients with late coronary artery patency the corresponding number was 6 out of 15. However, a significant increase in the concentration of thiobarbituric acid reactive substances was found for the whole group 24 and 48 hours after treatment. The change in concentration in serum correlated significantly with that of C reactive proteinan acute phase reactant (r = 0*62, P < 0.01)-but not to the serum activities of markers of infarct size such as creatine kinase B and lactate dehydrogenase. Conclusions-The fluorimetric assay used in this study to measure the concentration of thiobarbituric acid reactive substances seems to be an insensitive method of detecting reperfusion after thrombolysis for myocardial infarction.
Abstract
Objectives-To evaluate an increase in plasma concentration of thiobarbituric acid reactive substances as a non-invasive biochemical test of reperfusion after thrombolysis and to investigate the relation between the inflammatory response after acute myocardial infarction and the production of the substances. Methods-Venous samples were taken from 19 patients receiving thrombolysis for acute myocardial infarction before the start of therapy and every hour afterwards up to 5 hours and then at 24 and 48 hours and the concentration of thiobarbituric acid reactive substances measured. These substances are markers of lipid peroxidation induced by free oxygen radicals. Early reperfusion was judged by regression of ST elevation and late coronary artery patency from the results of coronary angiography 24-72 hours after thrombolysis. Results-The concentration of thiobarbituric acid reactive substances increased in only 6 out of 14 patients with signs of early reperfusion. In patients with late coronary artery patency the corresponding number was 6 out of 15. However, a significant increase in the concentration of thiobarbituric acid reactive substances was found for the whole group 24 and 48 hours after treatment. The change in concentration in serum correlated significantly with that of C reactive proteinan acute phase reactant (r = 0*62, P < 0.01)-but not to the serum activities of markers of infarct size such as creatine kinase B and lactate dehydrogenase. Conclusions-The fluorimetric assay used in this study to measure the concentration of thiobarbituric acid reactive substances seems to be an insensitive method of detecting reperfusion after thrombolysis for myocardial infarction. One postulated mechanism for reperfusion injury is the production of toxic free oxygen radicals from the onset of reperfusion, which has been shown in both animals5 and humans.6 Although the existence of irreversible reperfusion injury in humans is questionable, attention has been given to the concept of reducing myocardial injury at the time of reperfusion by treatment with free radical scavengers.7 In evaluating such treatment there is an obvious need for biochemical monitoring of production of oxygen radicals. Increased blood concentrations of products generated by free oxygen radicals may also provide a useful non-invasive marker of successful thrombolysis.
Malondialdehyde, formed by the breakdown of oxidised polyunsaturated fatty acids, has been used in several clinical studies as a marker of the production of free oxygen radicals.89 Davies et al found an increase in serum malondialdehyde concentration in blood samples collected one hour after the completion of streptokinase infusion in patients who subsequently showed patency of the infarct related artery, and a fall in those with persisting occlusion.'0 The overlap between the groups was minimal. Malondialdehyde concentration was measured with a colorimetric method based on the generation of a coloured adduct between malondialdehyde and thiobarbituric acid. As the method is fairly non-specific, however, the product(s) measured was expressed as the concentration of thiobarbituric acid reactive substances. Recently these findings have been confirmed in two studies in which malondialdehyde was analysed more specifically by high performance liquid chromatography." 12 In one of these studies, however, the overlap in malondialdehyde concentration between patients who showed reperfusion and those who did not was considerable. 12 Our aim was to evaluate an increase in the plasma concentration of thiobarbituric acid reactive substances as a non-invasive biochemical test of reperfusion after thrombolysis and to investigate the relation between the inflammatory response after myocardial infarction and the production of the substances. Of the 14 patients with signs of early reperfusion, only six showed an increase in the concentration of thiobarbituric acid reactive substances during the first two hours of thrombolytic treatment; in the 15 patients with late patency the corresponding number was also six. The average change in concentration between 0 and 2 hours was 7-5% (range 0-19 5%). Values uncorrected for haemodilution showed a significant decrease from 4 8,umol/l before the start of thrombolytic treatment to 4-4 ,umolIl two hours later (P<0.01).
Twenty four and 48 hours after the start of thrombolysis corrected concentrations of thiobarbituric acid reactive substances were significantly increased (3 5 (0O9),mol x 102/g (P < 0 05) and 3-7 (0-9),umol x 102/g (P < 0 001) respectively) compared with initial val- Increased concentrations of thiobarbituric lated after acid reactive substances were found in six of the 14 patients with signs of early reperfusion and in six of the 15 with coronary artery patency later during the course of acute myocardial infarction. Obviously, our results with the suggest that analysis of these substances, at e protein least in our hands, lacks discriminatory umal crea-power, which limits its use as a clinical test of 052) or reperfusion or as a research tool to monitor -ivity (r = the effects of treatment with free radical scavorrelation engers. The changes in concentrations that we barbituric measured were small in relation to the preci-I the con-sion of the analysis. In addition, errors were rides was introduced by correcting for haemodilution.
The discrepancy between our results and those of Davies et aPl' is difficult to explain, but differences in patient characteristics may play a part. The mean time from onset of usion the chest pain to start of thrombolysis was slightly has been longer in our study: five hours compared with :e shortly four hours. Secondly, differences in adjunclished the tive treatment might be important: all our oxidation patients received infusions of glyceryl triniients with trate. Glyceryl trinitrate is metabolised to oxidation nitric oxide, which in vitro acts as a scavenger thiobarbi-of free radicals.'9 Preliminary data from an ing to the ongoing study assaying malondialdehyde by method is high performance liquid chromatography, de is only however, show that malondialdehyde is with thio-formed after reperfusion in the presence of a us limnita-glyceryl trinitrate infusion. (H Ohlin, unpubrrectly to lished data). ) showed Whether more specific methods to measure ing occlu-malondialdehyde are better than measuring that an thiobarbituric acid reactive substances as a turic acid test of reperfusion is still unclear. Young et al )e a non-found a considerable overlap in malondialderfusion as hyde concentrations in patients who showed analysis reperfusion and those who did not,'2 whereas biochem-Giardina et al found good separation." In kinase B'7 these two studies, however, different assays and different criteria of reperfusion were used.
rement of
We found an increase in the concentration thiobarbi-of thiobarbituric acid reactive substances nce, high 24 and 48 hours after the beginning of aphy is thrombolysis, which is in agreement with preYoung et vious reports.20 21 The increases in C reactivê ations of protein and thiobarbituric acid reactive sub-;h perfor-stances concentrations were significantly cor-.ods, after related, indicating that these substances may olySis." 12 be produced as a part of the inflammatory the speci-response to myocardial injury. There is eviin detect-dence of increased production of oxygen free radicals in other inflammatory diseases formed a such as arthritis. 
